Genrix Bio
688443----
Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Genrix Bio(688443) the Revenue is 85.86 M (+240.2%);the EBIT is -165.79 M (+6.3%);the EPS is -0.45 (+2.22%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B240.21%
----
----
EBIT
-0.17B6.30%
----
----
EPS
-0.44972.22%
----
----
Upcoming earnings report - Q3 FY2026
Available dateOct 31, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly